Bisacodyl Therapy for Elderly Patients with Constipation

Introduction to Bisacodyl Therapy

The American Gastroenterological Association recommends starting bisacodyl at 5 mg orally once daily for elderly patients with chronic constipation, titrating up to a maximum of 10 mg daily if needed, and limiting use to short-term therapy (4 weeks or less) or as rescue therapy rather than continuous long-term treatment 1, 2, 3

The initial dose of bisacodyl should be 5 mg orally once daily to minimize the risk of diarrhea and abdominal cramping in elderly patients 2, 3
The maximum dose of oral bisacodyl is 10 mg daily, with titration based on symptom response and tolerability 3
Rectal suppositories (10 mg) are an alternative formulation that works within 30-60 minutes and may be preferred when digital rectal examination identifies fecal impaction 4

Short-term use of bisacodyl is defined as daily use for 4 weeks or less, based on high-quality trials 1, 2
Data beyond 4 weeks are limited, and more evidence is needed to understand tolerance and side effects with extended use 1, 2

Bisacodyl increases complete spontaneous bowel movements by approximately 4 additional movements per week compared to baseline, with moderate certainty evidence from two well-designed 4-week randomized controlled trials involving 730 patients 1
The most common adverse effects of bisacodyl are diarrhea (53.4% of patients) and abdominal pain/cramping (24.7% of patients), which are dose-dependent 2, 3
Elderly patients are particularly vulnerable to fluid and electrolyte disturbances, and should be monitored closely for dehydration and electrolyte imbalances 2, 4

Bisacodyl is appropriate after failure of fiber and over-the-counter osmotic laxatives, and provides faster relief than osmotic laxatives like lactulose 1
Bisacodyl works well in combination with other pharmacological agents for chronic idiopathic constipation, allowing for lower doses of each agent and potentially fewer side effects 1, 2

Bisacodyl should be started at 5 mg once daily, taken in the evening for morning effect, and reassessed after 3-7 days to increase to 10 mg if response is inadequate and tolerability is good 3
Monitoring parameters include bowel movement frequency, stool consistency using the Bristol Stool Form Scale, and adverse effects, particularly diarrhea and cramping 1, 2
Plan for discontinuation after 4 weeks of daily use, and transition to as-needed rescue therapy rather than continuous daily use 1, 2